CAR T-cell therapy for autoimmune disease
Chimeric antigen receptor (CAR) T-cell therapy is emerging as a promising treatment for autoimmune rheumatic diseases. New research presented this month at the 2023 American College of Rheumatology’s annual meeting showed positive results for the long-term remission of treatment-resistant systemic lupus erythematosus utilizing this novel treatment!
Read More »